Recurrence of Congenital Heart Disease in Cases with Familial Risk
Screened Prenatally by Echocardiography by Fesslova, Vlasta et al.
Hindawi Publishing Corporation
Journal of Pregnancy
Volume 2011, Article ID 368067, 9 pages
doi:10.1155/2011/368067
Clinical Study
Recurrence ofCongenitalHeart DiseaseinCases with
FamilialRisk Screened Prenatally byEchocardiography
VlastaFesslova,1 Jelena Brankovic,1 FaustinaLalatta,2 LauraVilla,3 ValerioMeli,4
LucianePiazza,1 and CristianRicci5
1Department of Pediatric Cardiosurgery, Center of Fetal Cardiology, Policlinico San Donato IRCCS, Via Morandi 30,
San Donato Milanese, 20097 Milan, Italy
2Clinical Genetic Unit, Fondazione IRCCS C` a Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
3Obstetrics and Gynecology Unit, Ospedale San Giuseppe, 20123 Milan, Italy
4Neonatal Intensive Care Unit, Ospedale B. Romeo, 98066 Patti, Messina, Italy
5Clinical Epidemiology and Biometry Unit, Policlinico San Donato IRCCS, 20097 Milan, Italy
Correspondence should be addressed to Vlasta Fesslova, cardiologiafetale.psd@grupposandonato.it
Received 10 May 2011; Accepted 1 August 2011
Academic Editor: Albert Fortuny
Copyright © 2011 Vlasta Fesslova et al.Thisisanopenaccessarticledistributed undertheCreative CommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objectives. To evaluate the recurrence of congenital heart disease (CHD) in pregnant women with familial risk who had been re-
ferred for fetal echocardiography. Material and Methods.1634 pregnancies from 1483 women with familial history of CHD in one
ormorerelatives were studied. Fetal cardiologic diagnosiswascomparedwithpostnatalﬁndings at6monthsoratautopsy. Results.
Totalrecurrence rate ofCHD was3.98%,4.06%in single familialrisk,2.9%in double, and 5%in multiple risk.It was3.5%in case
of one previously aﬀected child; 4.5% with 2 children; 5.2% with the mother alone aﬀected and 7,5% with father alone aﬀected
and 3.5% with a single distant relative. Exact concordance of CHD was found in 21.5% and a partial concordance in 20% of cases.
Conclusions.Our data showa higherrecurrence rateofCHD than previouslypublished data and high relative risk ratioscompared
to normal population.
1.Introduction
The inheritance of congenital heart disease (CHD) has been
analyzed in familial studies undertaken by Nora et al. [1–6]
and in studies on twins and siblings [7, 8] and the polygenic-
multifactorial model for inheritance has been generally
accepted.Thus,theincidenceofCHDinﬁrst-degree relatives
was predicted to be between 1 and 5%. However, the poly-
genic mode of inheritance seemed to be partly contradicted
by a higher recurrence risk (16%) for oﬀspring of patients
with CHD as reported by Whittemore et al. [9]o ra9 %
recurrence reported in parents with speciﬁc defects [10]. It
should be noted that the above are olderdata obtained in the
era before echocardiography. while nowadays our detection
of even mild forms of CHD have signiﬁcantly improved.
Afamily history ofCHDisafrequentreasonforreferring
a patient for fetal echocardiography. Prenatal counseling
in these patients is very diﬃcult, because it is not always
possible to exclude smaller or evolutive lesions in examined
fetuses and the ﬁnal prognosis of the aﬀected cases may be
sometimes completed only after birth. The recurrence rate
in populations with familial risk referred for fetal echocar-
diography was ﬁrst reported by Allan et al. [11]a n dt h e n
in two other studies [12, 13]. In 1998, our group analyzed
retrospectively a small series of fetal cases from families with
ah i s t o r yo fC H D[ 14]. We present now a prospective study
on a much larger number of cases, extending the followup to
at least 6 months, in order to detect even milder lesions.
2.Patientsand Methods
2.1. Patients. 1634 consecutive pregnancies from 1483 wom-
en referred for familial history of CHD were studied in our
center by fetal echocardiography between January 1995 and
June 2010. Patients’ families pedigree was collected for at2 Journal of Pregnancy
least three generations and the patients were informed about
the limits of the study.
The familial case with CHD who prompted the referral
was deﬁnedas theindexcase:itwaseitheran aﬀectedmother
or father, or a sibling of the current pregnancy, or more
distantrelativesofthe2nd-3rddegree;1477caseswerefound
to have a single familiar risk while 157 cases had multiple
risks (2–5 relatives with CHD). One hundred thirty-nine
w o m e nw e r ee x a m i n e di nt w o ,1 2i nt h r e ea n do n ei nf o u r
consecutive, pregnancies, respectively. There were 21 twin
pregnancies.
2.1.1. Inclusion/Exclusion Criteria. Only cases with a known
followup were included while mothers with pregestational
diabetes or those taking drugs during pregnancy were ex-
cluded,aswere the index cases aﬀected with Mendelian diag-
nosed syndromes or chromosomal anomalies, or cases of
consanguineous parents.
2.1.2. Methods. Echocardiographic studies were performed
using echocardiographic machines Acuson Sequoia 512,
Siemens, Erlangen, Germany and Vivid 7, General Electrics,
Healthcare Italy or Aloka Prosound Alpha 10, Tokyo, Japan,
applying standard methodology with use of 2D, Doppler
and Color Doppler techniques. These equipments had all a
very good imaging standard. Studieswere routinely recorded
ontovideotape orby digitalstorage ofthe echocardiographic
machines. All studies were performed by one single experi-
enced fetal cardiologist (V. Fesslova) and discussed with the
team of perinatal medicine.
Fetal cardiologic diagnosis of the cases was compared
with the ﬁndings at autopsy, or postnatally, at follow-up ex-
aminations at 6 months of age or later. Regarding the
diﬀerentialdiagnosisbetweenaphysiologicalpatentforamen
ovale and ASD secundum, we considered as a criterion the
diameter >8mminthethirdtrimesterand>5mmat1year
of age.
All live-born infants either underwent a cardiologic ex-
amination in our centre or, if carried out elsewhere, the
parents forwarded to us a follow-up questionnaire given to
them at the last fetal examination, completed by the team
that performed the examination. If necessary, the parents or
cardiologists of other centres were contacted by one of our
group in order to have a correct postnatal diagnosis.
2.1.3. Analysis of the Data. The data regarding the index case
and the echocardiographic ﬁndings of the examined fetus,
with his subsequent outcomes, were analyzed by means of
a computerized database (Filemaker Pro, VI, Claris Corp.,
Santa Clara, Calif, USA).
Cardiac defects were classiﬁed using the sequential seg-
mental classiﬁcation described by Tynan et al. [15]. We also
included the cases in which there was an uncertainty about a
precise cardiac diagnosis of the index case, in order to assess
the global recurrence of the population referred for familial
history.
Defects of the index case and of the examined fetus were
analyzed for concordance and discordance. The defect in
the examined fetus was described as exactly concordant if
it was identical to that one seen in the index case and con-
cordant for the group if the defect belonged to the same
spectrum of CHD as seen in the index case, that is, group of
shunts, conotruncal lesions, left and right heart obstructive
lesions, and laterality defects/dextrocardia, according to the
criteria used in previous studies [13, 16].
The recurrence rate of CHD was analyzed by subdividing
the population into categories of a single- or multiple-
familial risk and according to the type of CHD of the index
case (Tables 1 and 2), the recurrence rate being deﬁned as a
percentage of aﬀected fetuses for the category of familial risk
or for the type of CHD in the index case.
Relative recurrence risk ratios (RRs) with respect to the
normal populationwereestimated bymeans oflogisticlinear
regression performed by SASSoftware Package version 9.1.3.
comparing the frequencyof single typesofCHDrecurrent in
our population to the ﬁgures of prevalence of similar defects
in a study of Moons et al. [17] found in the population of
111.225 normal infants born in Belgium in the year 2002
(with a total prevalence of CHD of 8.3/1000).This study was
found to ﬁt better for a comparison with our population,
becauseitregards equallyaCaucasianpopulationand,main-
ly,hasahighnumberofnormalinfantsbornwithinthesame
year, with a detailed prevalence of single-cardiac lesions.
3.Results
3.1. Cardiac Lesions Found in Examined Fetuses. CHD was
found in 65 infants with 2 being twins. Figure 1 shows the
distribution of single types of lesions: more common were
septal defects: VSD (14 cases, 21.5% of the defects), ASD (8
cases, 12.3%), and AVSD and PS (in 6 cases, resp.).
Twelvecases(18.4%)werediagnosedonlyafterbirth:one
case with coarctationof theaorta who was examined in utero
only in the 2nd trimester, 7 small VSDs, and 4 ASDs—
conﬁrmed at 12 months of age, after the fetal ﬁndings in the
third trimester of a large foramen ovale (greater than 8mm)
and a large aneurysm of the foramen.
3.2. Total Recurrence Rate in Single Categories of Risk. Total
occurrence of CHD was 65/1634 (3,98%), 60/1477 (4.06%)
in caseswith single familiar risk, 2.9%(4/137)and 5%(1/20)
in pregnancies having, respectively, double and multiple risk
(Table 1).
When excluding the cases that were not diagnosed in
utero but found only after birth, the recurrence rate would
be lower—of 3.2% (53/1634). As we stated in the Patients
and Methods Section, the detailed analysis is based upon the
total number of CHD in infants at 6 months of age.
The recurrence rate of CHD was 3.5% (29/818) when
one previouschild was aﬀected, butincreased to 4.5% (1/22)
when 2 previous children had CHD.
When mother alone was aﬀected, the recurrence was
5.2% (13/250); with additional 1-2 relatives the recurrence
rate increased to 9.7% (3/31).
When father alone was aﬀected, the recurrence rate was
7.5%(7/93)and4.5%(1/22)with1-2otherrelativesaﬀected.Journal of Pregnancy 3
Table 1: Recurrence of congenital heart defects in cases with single- and multiple-familial risk.
Index case with CHD Total cases n.A ﬀected cases n.R e c u r r e n c e r a t e %
Single risk—total 1477 60 4.06
Previous child 818 29 3.5
Mother alone 250 13 5.2
Father alone 93 7 7.5
One relative II◦-III◦ 316 11 3.5
Double cases risk 137 4 2.9
2 previous children 22 1 4.5
1 previous child + 1 relative 23 — —
Mother + another relative 26 2 7.7
+ 1 previous child 8 1 11.1
+f a t h e r 3 1 6 . 7
+1r e l a t i v e 1 5
Father + another relatives 19 1 5.3
+p r e v .c h i l d 1 2 1 8 . 3
+1r e l a t i v e 7 — —
2 relatives II◦-III◦ 47 — —
Multiple cases risk 20 1 5
2 prev children + 1 relative 2 — —
Mother + prev. child or 2–4 relatives 5 1 20.0
Father + 2 relatives 3 — —
3-4 relatives II◦-III◦ 10 — —
Total double + multiple risk 157 5 3.2
Total series 1634 65 3.98
In cases of a single 2nd-3rd-degree relative aﬀected, the
recurrence was 3.5% (11/316).
3.3. Recurrence in Subsequent Pregnancies. Five fetuses of the
139womenwhowerefollowedin2pregnancieswereaﬀected
(3.6%), with concordant recurrence of ASD in 2 infants of
mothers aﬀected with the same lesion; another mother with
VSD had an infant with ASD and two siblings of index cases
with TGA and AVSD had both a VSD.
Twelve women who were followed in their 3rd pregnan-
cies had all normal infants: 2 were aﬀected mothers and one
aﬀected father who have each had an aﬀected child previ-
ously; 2 other aﬀected mothers had normal children in both
previous pregnancies, while in the remaining pregnancies
normal infants were born after one previously aﬀected child.
One woman, followed up in 4 pregnancies, after the ﬁrst
childwith TGA andwho had anotherdistant relative aﬀected
with an undeﬁned CHD, delivered normal oﬀspring in the
subsequent pregnancies.
Table 2 shows in detail the total recurrence rates in the
various subgroups of CHD present in the index cases, distin-
guishing the total rates, and those in siblings, oﬀspring, and
distant relatives. It is evident that the recurrence rates of dif-
ferent types of CHD varied between the categories of index
cases (i.e., recurrence rate in AVSD in siblings is 6.5% and
in aﬀected mothers increased to 1/4 (25%)). The recurrence
rate was highest in cases of pulmonary atresia and intact
septum (2/14 = 14.3%, with cases aﬀected with pulmonary
stenosis), in cases of Ebstein/non-Ebstein anomaly (2/21 =
9.5%). A high recurrence rate of 8.7% (2/23) was also found
in the index cases with dextrocardia, with a concordant
recurrent anomaly in one fetus (hypoplastic right ventricle
and pulmonary atresia), while the second fetus, of an index
case with dextrocardia, corrected TGA and pulmonary atre-
sia, had right isomerism and atrioventricular septal defect.
Corrected TGAand pulmonary atresia with VSD occurred at
ar a t eo f1 / 1 4= 6.7% and 1/19 = 5.3%, resp.). Surprisingly,
severe anomalies such as HLV and univentricular heart had
in our series a low recurrence rate of 1.25% and 1.5%, while
Fallot’s Tetralogy recurred at 6% rate.
Concordance between index cases and aﬀected fetuses is
summarized in Table S1 (available as a supplementary ﬁle).
Complete exact concordance was found in 14/65 cases
(21.2%).
Partialconcordance orconcordancewithin groupwas ob-
served in 13/65 (20%). When the mother alone was aﬀected,
an exact concordance occurred in 3/13 cases (23.1%) and
in case of a mother and other 3 relatives aﬀected; a partial
concordance occurred in further index cases of 5 mothers
and in one case when mother and a previous sibling were
aﬀected.
W henthefatheralonewasaﬀected,anexactconcordance
occurred in 1/7 cases and a partial one in another case.
When one previous child was aﬀected, the complete con-
cordance was 8/29 (27.6%) and a partial one in 2/29 (6.9%).4 Journal of Pregnancy
Table 2: Recurrence of congenital heart defects in subgroups of CHD in index cases: total recurrence rate and recurrence rates in siblings,
oﬀspring, and distant relatives.
Index case diagnosis Total index
cases n.
Aﬀected cases
n. Recurrence diagnosis Recurrence
rate Tot %
Recurrence
rate in
siblings %
Recurrence in
oﬀspring %
M, F
Recurrence
rate in
Relatives %
Anomalies of a-v connections
(i) UVH 65 1 1 HLV 1/65 = 1.5 1/52 = 1.9 M 0/1, F 0/1 0/11
(ii) HLV 81 1 1 HLV 1/81 = 1.23 1/80 = 1.25 — 0/1
(iii) TrAtr 37 — — — — — —
(iv) AVSD 64 5
1 VSD; 1 AVSD+ HLV
2 AVSD incomplete;
1 cor triatriatum.dx.
5/64 = 7.8 3/46 = 6.5 M1 / 4= 25.0,
F0 / 1
1/13 = 7.7
(v) Ebstein/Dyspl Tr 21 2 1 LSVC; 1 CoA 2/21 = 9.5 2/15 = 13.3 M 0/1, F 0/5 —
Conotruncal anomalies
(i) Tetralogy of Fallot 151 9
1D O R V ;1A S D + P S ;
2 VSD; 1 PLSVC; 1 PS;
1T F + a g e n . P V ,
1 Patr+IVS
8/151 = 5.3 2/73 = 2.7 M1 / 2 6= 3.8,
F2 / 1 1= 18.2
3/41 = 7.3
(ii) PAtr + VSD 19 1 1 VSD 1/19 = 5.3 1/11 = 9.1 M 0/1 0/7
(iii) PAtr + IVS 14 2 2 PS 2/14 = 14.3 2/10 = 25 — 0/4
(iv) DORV 15 — — — — — —
(v) Truncus 20 1 1 ASD 1/20 = 51 / 2 0 = 5— —
(vi) TGA 104 3 2 VSD; 1 PS 3/104 = 2.88 2/66 = 3.03 M 0/2 1/36 = 2.8
(vii) TGAc 15 1 1 TGAc + VSD + PAtr 1/15 = 6.7 1/10 = 10.0 M 0/1, F 0/2 0/2
Shunts:
(i) VSD 239 10
1 TrAtr +TGA+VSD;
2 VSD; 1 TF; 2 AVSD
1 VSD + ASD + PS
2A S D ;1t r u n c u s
10/239 = 4.2 2/126 = 1.59 M5 / 6 6= 7.5,
F1 / 1 4= 7.1 2/33 = 6.1
(ii) VSD + ASD 23 1 1 TGA 1/23 = 4.35 1/18=6.3 M 0/2, F 0/1 0/2
(iii) ASD 194 8
2A S D ;3V S D ;
1 VSD + ASD;
1 AVSD + HLV + HAo;
1A S D+P A P V D+
agenesis right lung
8/194 = 4.1. 1/59 = 1.7 M5 / 8 8= 5.7,
F1/20 = 5–0 1/27 = 3.7
(iv) Ductus Arteriosus 34 1 1 ASD 1/34 = 2.94 0/10 M1 / 1 2= 8.3,
F0 / 1 0/11
Anomalies of semilunar valves/great arteries:
(i) CoA/Interr Ao arch 134 3 1 HLV; 1 ASD;1CoA 3/134 = 2.24 1/84 = 1.2 M1 / 1 7= 5.9,
F1 / 7= 14.3 0/26
(ii) AS 115 5 1V S D ;2A S ,
1E b s t e i n ;1T G A+C o A 5/115 = 4.3 0/28 M2 / 2 7= 7.4,
F2 / 3 4= 5.9
1/26 = 3.8
(iii) PS 76 4 1H L V ;1P S ;
1C o A ,1P A P V D 4/76 = 5.3 2/37 = 5.4 M 0/18,
F1 / 6= 16.7 1/15 = 6.6
Various:
(i) P/TAPVD 22 — — 0/22- 0/12 M 0/2, F 0/3 0/5
(ii) Heterotaxy syndrome 22 1 1 AVSD + left isom; 1/22 = 4.5 1/19 = 5.3 — 0/3
(iii) Dextrocardia + svi, s.sol 23 2 1H R V+P A t r ;
1A V S D+r i g h ti s o m 2/23 = 8.7 2/14 = 14.3 M 0/5, F 0/2 0/2Journal of Pregnancy 5
Table 2: Continued.
Index case diagnosis Total index
cases n.
Aﬀected cases
n. Recurrence diagnosis Recurrence
rate Tot %
Recurrence
rate in
siblings %
Recurrence in
oﬀspring %
M, F
Recurrence
rate in
Relatives %
Other (miscel.) 41 1 1 VSD 1/41 = 2.4 0/17 M 0/7, F 0/6 1/11 = 9.1
CHD undeﬁned 105 4 1 VSD; 2 CoA, 1 TGA 4/105 = 3.8 3/30 = 10 F 0/1 1/74 = 1.35
Total 1634 65 3.98
n:number, CHD:congenitalheart disease,c.:cases,F: father,M: mother,a-v: atrioventricularUVH: univentricularheart, AVSD: atrioventricularseptaldefect,
HLV: hypoplastic leftventricle,HAo: hypoplastic aorta, HRV: hypoplastic right ventricle,TrAtr: tricuspidatresia,Dyspl Tr: dysplasiaof the tricuspidvalve, PV:
pulmonary valve; PAtr: pulmonary atresia, IVS: intact ventricular septum, VSD: ventricular septal defect, DORV: double outlet right ventricle, TF:T e t r a l o g y
of Fallot, TGA: transpositionof great arteries,TGAc: corrected transpositionof great arteries,CoA: coarctationof aorta, Interr Ao: interrupteda o r t i ca r c h ,A S :
aortic stenosis, PS: pulmonary stenosis, ASD: atrial septal defect ostium secundum; P/TAPVD: partial/total anomalous pulmonary venous drainage; PLSVC:
persistent leftsuperior vena cava; s.: syndrome; isom: isomerism;svi: situsviscerum inversus; s.sol: situs viscerum solitus,miscel.: miscellaneous.
D x c+P a t r+H R V
PAIVS
TGAc
Tr.atr
Ebstein
DORV
Truncus
TF
PLSVC
Heterotaxy
AS
TGA
ASD + VSD/PAPVD
HLV
CoA
AVSD
PS
ASD
VSD
1
1
1
1
1
1
1
2
2
2
2
3
3
4
5
6
6
14
6
Types of recurrent CHD
02468 1 0 1 2 1 4
Figure 1: Types of recurrent CHD. Dxc + Patr + HRV: dextrocar-
dia+pulmonaryatresia+hypoplasticrightventricle,PAIV:pulmo-
nary atresia and intact septum, TGA-TGAc: transposition of great
arteries, corrected transposition of great arteries, DORV: double
outlet right ventricle, TF: Tetralogy of Fallot, PLSVC: persistent
left superior vena cava, AS: aortic stenosis, ASD: atrial septal de-
fect, VSD: ventricular septal defect, PAPVD: partial anomalous
pulmonary venous drainage, HLV: hypoplastic left ventricle, CoA:
coarctation of aorta, PS: pulmonary stenosis; AVSD: atrioventricu-
lar septal defect.
In 34cases (51.5%),there was a discordance in the typeof
cardiac lesion.
(1) Lesions of a similar gravity in 5 cases.
(2) Milder lesions in 19 cases.
(3) More complex CHD in 10 cases.
Thetypeofr ecurr enc ec ouldnotbedeﬁnedin4cas esbe-
causeofa nonspeciﬁcdiagnosis ofthecardiacanomaly in the
index case.
3.4. Multiple Familiar Risk. Out of 5 aﬀected fetuses with
double/multiplefamiliarrisktherewasonecasewithanexact
concordance of incomplete AVSD in 3 generations—mother,
grandfather, and examined fetus, while two other relatives
of the same family had a complex form of AVSD with
coarctation of the aorta and another, a more distant relative
had a valvular aortic stenosis.
Table 3 shows the relative risk ratios for speciﬁc cardiac
defectsascomparedtothedataofMoonsetal.[17],generally
ours are much higher with respect to the risks of a normal
population, mainly as for VSD, Tetralogy of Falot and pul-
monary atresia with intact septum.
4.Discussion
Epidemiology and genetics of cardiac malformations have
beenanobjectofseveralstudiesoverseverallastdecades.The
large epidemiological Baltimore Washington Infants Study
[18, 19] that analyzed a cohort of children with CHD from
1981 to 1989 has shown also that 30% of aﬀected cases were
associated with other genetic disorders. In the population of
nonsyndromicchildren,therewasarecurrenceof4.9%inthe
ﬁrst degree relatives and the recurrence rate was particularly
high in families with HLV and coarctation of the aorta (13
and 8%, resp.).
Nora[1]introducedin1968thehypothesisofamultifac-
torial mode of inheritance of CHD in the majority of cases,
suggesting that several loci could interact in association with
environmental factors. They reported a recurrence rate of
about 3%, for healthy nonconsanguineous parents with one
child aﬀe c t e di n c r e a s i n gu pt oa b o u t1 0 % ,a f t e rh a v i n ga n -
other aﬀected child; but the risk was variable for diﬀerent
types of CHD.
SubsequentstudiesofBurnetal. [7, 8]pr o videdc ouns el-
ingﬁguresfordiﬀerenttypesofcardiaclesionsinsiblingsand
oﬀspring of cases with CHD, reporting a higher recurrence
rate for children of aﬀected mothers compared to the cases
with an aﬀected father (4.1% and 2.2%, resp.).
Higher recurrence rates in the oﬀspring of mothers with
CHD with and without surgical treatment (of 16.1%) were
reported by Whittemore et al. [9], while Rose et al. [10]
found a 9% recurrence in parents with speciﬁc defects.
A positive family history of CHD is a frequent cause for
the referral for prenatal cardiac investigation which led to
the ﬁrst study of the recurrence of CHD in the population
of mothers referred for fetal echocardiography for a family
history [13]. In this study, the authors reported a total
recurrence rate of 1/52 (1.9%) after one previously aﬀected
child and 1/10 after two previously aﬀected children. In6 Journal of Pregnancy
Table 3: Relative risks ratios—comparisonbetween our series and normal population (Moons et al.).
CHD Our series (‰) Moons et al. (‰) RR Conﬁdence limits (95%) P-value
HLV 1/1634 (.6 ) 10/111225 (.09) 6.8 0.9–53.2 0.067
UHV 1/1634 (.6) 9/111225 (.08) 7.6 0.96–59.8 0.055
TF 9/1634 (5.5) 52/111225 (.5) 11.8 5.8–24.1 0.0001
PA + VSD 1/1634 (.6) 6/111225 (.05) 11.4 1.4–94.3 0.024
PAIVS 2/1634 (1.2) 6/111225 (.05) 29.7 4.6–112.6 0.0001
Truncus 1/1634 (.6) 7/111225 (.06) 13.7 1.7–111.1 0.0145
TGA 3/1634 (1.8) 29/111225 (.3) 7.05 2.1–23.2 0.0013
TGAc 1/1634 (.6 ) 3/111225 (.03) 22.7 24–218 0.007
CoA 3/1634 (1.8) 46/111225 (.4) 4.5 1.4–14.3 0.0123
AVSD 5/1634 (3.1) 37/111225 (.3) 9.2 3.6–23.5 0.38
Ebstein 2/1634 (1.2) 3/111225 (.03) 63.8 10.7–382.4 <0.0001
PS 3/1634 (1.8) 88/111225 (.8) 2.3 0.7–7.3 0.007
As 5/1634 (3.1) 26/111225 (.2) 18.5 7.1–48.1 <0.0001
ASD 8/1634 (4.9) 162/111225 (1.5) 4.7 2.3–9.7 <0.0001
VSD 10/1634 (6.1) 303/111225 (2.7) 2.3 1.9–4.2 0.0008
T/PAPVD 1/1634 (.6) 28/111225 (.3) 3.4 0.46–25.1 0.2277
CHD:congenitalheart disease,HLV:hypoplasticleftventricle,UVH: univentricularheart, TF:Tetralogy ofFallot,PAtr:pulmonaryatresia,PAIVS:pulmonary
atresia + intact ventricular septum, TGA: transposition of great arteries, TGAc: corrected transposition of great arteries, CoA: coarctation of aorta, AVSD:
atrioventricularseptaldefect,PS:pulmonarystenosis,AS:aorticstenosis,ASD:atrialseptaldefectostiumsecundum,VSD:ventricularseptaldefect,T/PAPVD:
total/partial anomalous pulmonary venous drainage.
amore recentlarge studyin asimilar population,Tynan etal.
[15] reported a recurrence rate of 2.7%, in fetuses with one
or more ﬁrst-degree relatives with CHD.
The present study included also the cases studied by fetal
echocardiography because of a family history of CHD in ei-
ther ﬁrst degree or more distant relatives. We insisted on
a ﬁnal cardiologic examination of the child at least at 6
months of age or later, in order to detect even those smaller
anomalies, that are diﬃcult to visualize inthe fetus [20]. Our
results demonstrate a higher recurrence rate for CHD than
do the above two fetal studies, with a total recurrence rate of
3.98%, a rate of 4.06% in cases with a single familial risk, of
2.9% in cases with double risk and 5% (1/20) in those with
multiple risks.
The recurrence rate would have been lower if we have
had considered only cases diagnosed during fetal life (3.2%),
more similar to the results of Gill et al. [13]. We felt it
essentialthatweshouldconsiderasrecurrenteventhemilder
congenitalheart lesions, such as small VSDs, discovered after
birth that are often not detectable by fetal echocardiography
as well as ASD that cannot usually be seen in the fetus,
unless they are truly large. The occurrence of these defects
are important for the family that is usually very anxious after
a previous experience with a cardiac problem and also for
our own knowledge of the recurrence.
Asfor thesingle categoriesoffamilial risk, the recurrence
rate in our study was 3.8% (30/784) when one previous
child was aﬀected increasing to 4.8% (1/21) with 2 previous
children with CHD, in agreement with several other reports
[2, 8, 12].
Our recurrence rates for siblings and oﬀspring corre-
spond tothose reported by Noraand Nora[3]a n dR o s ee ta l .
[10] and others based upon the postnatal data, but they are
lower than the those of Whittemore et al. [9]w h or e p o r t e da
very high incidence rate (60/372–16.1%)in live-born infants
of mothers with and without surgical treatment of CHD.
We found a diﬀerence between the recurrences in oﬀ-
spring of aﬀected mothers and fathers. The preponderance
of aﬀected oﬀsprings of mothers with CHD may be at least
partly explained by cytoplasmatic inheritance, that is, trans-
mission of maternal cytopathy, while the paternal transmis-
sion is of about 2% lower than the maternal one [6, 8, 9].
This mechanism is more obvious in some speciﬁc maternal
cardiac lesions such as AS, CoA, PS, VSD, and AVSD. On the
whole, mothers with CHD are very likely to be more vulner-
able to teratogens than fathers [8].
Frequency of CHD found among our aﬀected fetuses cor-
responds to the ﬁgures reported in a large epidemiological
study of Moons et al. [17] that indicated a global prevalence
of CHD in Belgium in the 2002 of 8.3/1000. Another recent
study in Sweden, in contrast, reported a much lower preva-
lence of 2.8/1000 [21]. These diﬀerences show how diﬃcult
it is to determine the correct prevalence and relative risk for
CHD, very likely due to diﬀerent assessment policies.
Recurrence risk ratios of our series with familial history
of CHD show high ﬁgures in comparison to the data of the
study of Moons et al. [17] regarding the normal population,
mainly for VSD, Tetralogy of Fallot, and pulmonary atresia
with intact septum.
High relative risk recurrence ratios both of a speciﬁc and
discordant CHD in ﬁrst-degree relatives compared with the
normal population prevalence were reported also by Øyen et
al. [22, 23] in a large national epidemiological cohort study
regarding the period 1977–2005.Journal of Pregnancy 7
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atives. Their study includes, however, also cases with associ-
ated chromosomal or extracardiac anomalies.
4.1. Concordance of Congenital Heart Lesions. Our results
conﬁrm a large variability in the recurrence of cardiac le-
sions, both in cases with multiple familial risk factors and
in consecutive pregnancies, in agreement with other reports
[8, 13]. In our series we found a complete concordance
of recurrent CHD in 21.2% and a partial concordance in
additional 20% of cases. A higher concordance was reported
by Corone et al. [24] in 48% of aﬀected ﬁrst degree relatives
andin28%ofaﬀectedsecond-andthird-degree relativesand
byAnderson[25]whofoundacompleteconcordancein31%
of aﬀected siblings and in 46% of aﬀected parents. Gill et al.
[13]foundanexactconcordancein37%andagroupconcor-
dance in 44%; in families with two or more recurrences, the
exact concordance was 55% and the exact concordance was
high in AVSD 4/5 (80%) and laterality defects 7/11 (64%).
Among discordant pairs of lesions, some occur more
frequently and mainly within the group of septal defects
(ASD,VSD,AVSD)orbetweenTF, TGA,and VSD.We found
also a case of recurrence of PS after the previous pulmonary
atresia. Equally, the variability between diﬀerent types of
the left ventricular obstructive lesions has been reported in
several studies [24, 26].
4.2. Recurrence of Speciﬁc Cardiac Lesions
4.2.1. Atrioventricular Septal Defect. Familial occurrence of
AVSD is reported both in the presence of euploidy and
aneuploidy (trisomy 21), with a rate in siblings about 3-4%
[2–5, 27, 28], the recurrent lesions being often concordant.
The total recurrence rate in our study was 7.8%, 6.5% in sib-
lings, all aﬀectedcases beingnonsyndromic. Insome families
there were reported discordant lesions such as VSD, ASD,
patent ductus arteriosus, and hypoplastic right ventricle
with PS [29], similarly to our results. Vertical transmission
found in selected pedigrees suggests an autosomal-dominant
mechanism, with monogenic or oligogenic inheritance [8,
27]. Recurrence risk is about 10% for an aﬀected parent,
higher for mothers, 14% [28].
4.2.2. Tetralogy of Fallot. Familial recurrence ofCHD among
patients with nonsyndromic TF was reported of 2.5–3% [1,
5] and 5.5% in our study. The model of transmission ofTF is
thought to be prevalently an autosomal recessive mechanism
in selected families [30]. An etiologic relationship was re-
ported for the conotruncal lesions, PS, and VSD [26].
Transposition of great arteries is generally considered to
have a sporadic occurrence in families, with a risk of 2, 5-6,
and9%.Inamorerecentstudy[31]therecurrenceinsiblings
was 1.8%, usually with a concordant lesion. This was not the
case in our series, in which the total recurrence was 2.88%
and 3.03% in siblings, with recurrence of VSD and PS.
Corrected transposition of great arteries had a higher
recurrence of 5.2% in the study of Piacentini et al. [32]t h a n
in ours. In our population total recurrence was 1/15 = 6.7%
and 1/10 = 10% in siblings, with an occurrence of a more
complex form of the corrected transposition.
4.2.3. Left Heart Lesions. J. J. Nora and A. H. Nora [6]i n d i -
cate a recurrence in siblings and oﬀspring of 2.2/3.9% for AS
and 1.8/2.7% for aortic coarctation. Allan et al. [11]r e p o r t
a recurrence rate of 1/28 (3.6%) of aortic valve atresia and
1/15(6.7%)ofcoarctation.In ourpopulationtherecurrence
for aortic stenosis was 4.3%, 2/27 (7.4%) when the mother
was aﬀected and 2/34 (5.9%) when the father was aﬀected.
Lower total recurrence was found for coarctation (2.24%)
and was equally higher among aﬀected mothers than fathers,
1/17 (5.9%) and 1/7 (14.3%), respectively.
O b s t r u c t i v el e s i o n so ft h el e f to u t ﬂ o wt r a c ta r ep r e s u m e d
to be due to an altered embryonic blood ﬂow and may occur
in families with variable degrees of severity starting with
bicuspidaortic valve, AS,coarctationofthe aorta, and HLHS
suggesting a genetic predisposition to the ﬂow alterations
[29, 33]. An autosomal recessive transmission has been sug-
gested [34].
Right-sided obstructive lesions and membranous ventricu-
lar septal defects a r ea l s op r e s u m e dt ob ed u et oa l t e r e dﬂ o w
and appear to be developmentally heterogeneous, occurring
infamilial combinationswith conotruncalmalformations, as
expressionofa“conotruncalsusceptibility”or“formefrusta”
manifestations of conotruncal abnormalities [24].
Pulmonary atresia with intact ventricular septum and hy-
poplastic right heart isconsideredtobea single-gene disorder
[35] and in our study was found in 2 male siblings, with a
high total recurrence rate of 2/14 (14.3%).
Pulmonary stenosis is known to be frequently associated
with Noonan syndrome. An unusually high recurrence rate
of 9.1% was reported in the Baltimore Washington Infants
Study [19], while others reported a recurrence close to 2–
2.7%. In our series, the total recurrence was 5.3% and in
siblings 5.4%. The recurrent cases were heterogeneous (only
one recurrence was concordant, other cases presented HLV,
CoA, and partial anomalous venous drainage.).
Ventricular septal defect has a recurrence rate between 1.7
and 4.2% in the literature [6]; its prevalence in the study of
Moons et al. [17] was 2.72. Our total recurrence rate was
4.2%, with 1.59% in siblings and 7% in aﬀected mothers
and fathers. The recurrent lesions were either concordant
or discordant (tricuspid atresia with VSD, TF, AVSD with
hypoplastic right ventricleandVSD associated with ASDand
PS and also TGA).
Familial atrial septal defect isusually dueto an autosomal
dominanttransmission. However,thegeneticsofASDiscon-
sidered to be heterogeneous. The ASD associated with
conduction abnormalities seems to be a distinct entity with
ad i ﬀerent histopathologic origin, with possible relation to
autoimmuneandconnectivetissuedisorders[19].Therecur-
rence of ASD was reported between 2.5 and 3.7% [6, 26, 27]
and it was 4.1% in our entire series, but higher in fetuses
from aﬀe c t e dm o t h e r sa n df a t h e r s( 5 . 7 %a n d5 % ) .
4.2.4. Laterality Defects. Recurrence for the laterality defects
have been reported to be between 2 and 4.75% [9, 25].8 Journal of Pregnancy
In our series, we have found a total recurrence of 1/22
(4.5%) in index cases with left and right isomerism and a
concordant recurrence in siblings of 1/19 (5.3%) with left
isomerism and AVSD, but with diﬀerent associated intrac-
ardiac lesions.
High relative risk ratio for heterotaxy was reported by
Pradat and Øyen et al. [21, 22].
Outof22caseswithdextrocardia,eitherwithsitussolitus
and or inversus, recurrent lesions occurred in 2 cases (total
recurrence 8.7% and rate in siblings 2/14–14.3%).
5.Conclusions
Our data demonstrate a higher recurrence rate of CHD than
in previously published data, mainly thanks to an improved
detection of even milder forms of CHD both in utero and
after birth, and conﬁrm the speciﬁc transmission of certain
types of CHD in some families indicating a genetic compo-
nent.Ongoinggeneticand molecularstudiessuggestintrigu-
ing links between certain speciﬁc cardiac lesions in some
familial pedigrees. The clinical signiﬁcance of data regarding
the recurrence of CHF is evident, particularly for preconcep-
tion and prenatal counseling.
The couple receiving prenatal counseling and surveil-
lanceshouldbeinformedoftheimpossibilityofatotalexclu-
sion of the occurrence of some small defects and evolutive
lesions as coarctation and that the global prognosis of the
infant can be sometimes completed only after birth.
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Abbreviations
CHD: Congenital heart disease
HLHS, HLV: Hypoplastic left heart syndrome, hypoplastic
left ventricle
AVSD: Atrioventricular septal defect
VSD: Ventricular septal defect
ASD: Atrial septal defect ostium secundum
TGA: Transposition of great arteries
PS: Pulmonary stenosis
AS: Aortic stenosis
CoA: Coarctation of the aorta
TF: Tetralogy of Fallot
TGA: Transposition of great arteries
TGAc: Corrected transposition.
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